Although IL-6 specific treatments (e.g. tocilizumab) have been developed, but not yet tried as a treatment for COPD, one case report describes worsening of emphysema during treatment for rheumatoid arthritis [55]. Here, IL6 is linked to chronic obstructive pulmonary disease.